Walvax Biotechnology Market Cap

Walvax Biotechnology has a market cap or net worth of 16.22 billion as of April 25, 2025. Its market cap has decreased by -34.37% in one year.

Market Cap

16.22B

Enterprise Value

15.02B

Revenue

2.82B

Ranking

n/a

PE Ratio

114.06

Stock Price

10.09

Market Cap Chart

Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 16.22B, an increase of 18.94%. That is a compound annual growth rate of 1.21%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2025	16.22B	-16.06%
Dec 31, 2024	19.32B	-48.62%
Dec 29, 2023	37.60B	-41.50%
Dec 30, 2022	64.27B	-28.12%
Dec 31, 2021	89.42B	50.25%
Dec 31, 2020	59.52B	19.33%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	324.10B
Shenzhen Mindray Bio-Medical Electronics	265.58B
WuXi AppTec	156.42B
Zhangzhou Pientzehuang Pharmaceutical.,	123.71B
Aier Eye Hospital Group	116.59B
Sichuan Biokin Pharmaceutical	104.93B
Yunnan Baiyao Group Co.,Ltd	103.65B
Shanghai United Imaging Healthcare	102.83B

Market Cap Rankings